National Association of Testing Authorities, Australia
Scope of Accreditation
Western Diagnostic Pathology
Site
Myaree Laboratory – Healius Pathology Pty Ltd
Accreditation No.
3158
Site No.
3151
Date of Accreditation
24 May 1991
Contact
Mr Saverio Scriva
P: +61 (08) 93170725
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Withdrawn
Myaree Laboratory – Healius Pathology Pty Ltd
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2021
Last Activity Date
21 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Corporate OLN (class 3) | Not applicable | Not applicable |
| Pre-examination processes | Pre-analytics | Not applicable |
| RCPA training site - Anatomical pathology | Not applicable | Not applicable |
| RCPA training site - Chemical pathology | Not applicable | Not applicable |
Chemical Pathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2021
Last Activity Date
12 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Ethanol; Lithium |
| Carbamazepine; Digoxin; Phenytoin (dilantin); Valproate (valproic acid, epilim) | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Human chorionic gonadotropin (hCG); Prostate specific antigen (PSA); α-Fetoprotein (AFP) |
| Serum | Prostate specific antigen (PSA); Prostate specific antigen (PSA) fractions and derived index; Thyroglobulin | |
| β2-Microglobulin (B2M) | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Adrenocorticotropic hormone (ACTH) |
| Renin | ||
| Plasma; Serum | Aldosterone | |
| C-peptide; Growth hormone; Insulin | ||
| Dehydroepiandrosterone sulfate (DHEAS); Sex hormone binding globulin (SHBG); Testosterone - Free; Testosterone - Total | ||
| Cortisol; Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin | ||
| Insulin | ||
| Saliva | Cortisol | |
| Serum | Anti-Mullerian hormone (AMH) | |
| Insulin-like growth factor 1 (IGF-1, somatomedin C) | ||
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | Troponin |
| Pleural fluid | N-Terminal-pro b-type natriuretic peptide (NT-proBNP) | |
| Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP) | |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Haptoglobins |
| α1-Antitrypsin | ||
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Ascitic fluid; Drainage fluid; Pleural fluid | Albumin; Amylase; Cholesterol - Total; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Potassium; Protein - Total; Sodium; Triglycerides; Urea |
| Cerebrospinal fluid (CSF) | Glucose; Protein - Total | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; Calcium - Total; Chloride; Cholesterol - HDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; High sensitivity C-reactive protein (CRP); Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Plasma; Serum; Urine | Osmolality | |
| Serum | Calcium - Ionised | |
| Urine | Amylase; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for foetal lung maturity and/or foetal abnormalities | Amniotic fluid | α-Fetoprotein (AFP) |
| Placental growth factor (PGF, PLGF) | ||
| Chemical pathology - Investigation for folate deficiency | Plasma; Serum | Folate |
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | C13; C14 |
| Chemical pathology - Investigation of functional intestinal disorders | Breath | Hydrogen/methane |
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Serum | Free β-human chorionic gonadotropin (free β-hCG); Pregnancy associated plasma protein A (PAPP-A) |
| Chemical pathology - Iron studies | Plasma; Serum | Iron; Transferrin |
| Ferritin | ||
| Chemical pathology - Markers of bone metabolism | Plasma | c-Telopeptide (CTx) |
| Serum | Procollagen type 1 N-terminal propeptide (P1NP) | |
| Urine | n-Telopeptide (NTx) | |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma | Amino acids |
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | 1,25-Dihydroxyvitamin D; 25-Hydroxyvitamin D; Cobalamin (vitamin B12) |
| Serum | Cobalamin (vitamin B12) | |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Thyroid stimulation immunoglobulins | ||
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-thyroglobulin antibodies (Tg) |
| Anti-thyrotropin receptor antibodies (TSHR) | ||
| Anti-cyclic citrullinated peptide antibodies (CCP) | ||
| Rheumatoid factor | ||
| Anti-thyroid peroxidase antibodies (TPO) | ||
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin; Elastase |
| Plasma; Serum | Cryoglobulins | |
| Serum | Detection and quantitation of free kappa and free lambda light chains | |
| Albumin; Detection and amount of paraproteins; α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | ||
| Serum; Urine | Characterisation of paraproteins | |
| Urine | Albumin; Detection and amount of paraproteins; α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma; Serum | Total immunoglobulin E |
| Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M | ||
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Plasma | Mycobacterium tuberculosis cell mediated immune response; Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Hepatitis A virus (HAV); Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human immunodeficiency virus (HIV); Rubella IgG antibody; Syphilis Treponema pallidum antibody; Toxoplasma |
| Helicobacter pylori |
Cytology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2021
Last Activity Date
12 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical tissue; Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Vaginal smears; Vaginal tissue; Vault smears | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Nipple discharge | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program | Liquid based cytology specimens from cervix; Liquid based cytology specimens from vaginal vault | Human papilloma virus (HPV); Cytological examination; Review and reporting of cervical cytological material |
Genetics
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Cytogenetics - Detection of defined, unbalanced chromosomal abnormalities by in-situ hybridisation techniques | Amniotic fluid; Blood; Bone marrow; Chorionic villus tissue; Other tissues - Non-malignant | Cytogenetic analysis and reporting |
| Cytogenetics - Karyotype detection of unbalanced abnormalities | Amniotic fluid; Blood; Bone marrow; Tissues | Constitutional genetic abnormalities |
| Amniotic fluid; Blood; Tissues | Constitutional genetic abnormalities |
Haematology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2021
Last Activity Date
12 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material; Histological examination |
| Haematology - Diagnosis of thalassemia | Blood | Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens; Presence of foetal red blood cells |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes |
| Differential number; Morphology; Sideroblasts/siderocytes - Perl's iron stain | ||
| Differential number; Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet aggregation |
| Collagen - Adenosine (COL/ADP); Collagen - Epinephrine (COL/EPI) | ||
| Collagen binding activity | ||
| Plasma | Activated protein C (APC) resistance; Anti-Xa activity; Anti-thrombin III; Factor IX; Factor VIII; Factor XI; Factor XII; Lupus anticoagulant; Protein C and protein S; Von Willebrand factor (vWF); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | |
| Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT); Thrombin time (TT) | ||
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence |
| Haemoglobin fraction (S, C, D, E) - Quantitation; Other abnormal haemoglobins | ||
| Haematology - Investigation of haemolysis | Blood | Cold agglutinins |
| Urine | Haemoglobin (Hb); Haemosiderin | |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen | CD10; CD103; CD117; CD11b; CD11c; CD13; CD138; CD14; CD16; CD19; CD2; CD20; CD22; CD23; CD25; CD3; CD33; CD34; CD38; CD4; CD45; CD5; CD56; CD57; CD7; CD8; HLA-DR antigen; Kappa light chains; Lambda light chains |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Infectious mononucleosis |
Histology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2021
Last Activity Date
12 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in-situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
Immunohaematology
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Immunohaematology - Blood group antibody detection | Blood | Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test) |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Other blood group antibodies; Red blood cell phenotyping; Rh | ||
| Antibody titration |
Immunology
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen | CD10; CD103; CD11b; CD11c; CD13; CD138; CD14; CD16; CD19; CD2; CD20; CD22; CD23; CD25; CD3; CD33; CD34; CD38; CD4; CD45; CD5; CD56; CD57; CD7; CD8; HLA-DR antigen; Kappa light chains; Lambda light chains |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA) |
| Serum | Anti-cardiolipin antibodies (ACA); Anti-deamidated gliadin antibodies; Anti-extractable nuclear antigen antibodies (ENA); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG) | |
| Anti-endomysial antibodies (EMA); Anti-gastric parietal cell antibodies (GPC/PCA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1, AMA M2); Anti-smooth muscle antibodies (SMA) | ||
| Anti-intrinsic factor antibodies (IF) | ||
| Anti-double stranded DNA antibodies (dsDNA) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing (purified native and/or recombinant allergens)) | Serum | Ara h2 - Peanut; α-Lactalbumin - Milk; β-Lactoglobulin - Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Ampicilloyl group; Penicilloyl G; Penicilloyl V |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Budgerigar feathers; Canary bird feathers; Cat dander; Chicken feathers; Cow dander; Dog dander; Duck feathers; Finch feathers; Goat epithelium; Goose feathers; Guinea pig epithelium; Hamster epithelium; Horse dander; Mouse epithelium; Mouse serum proteins; Mouse urine proteins; Parakeet feathers; Parrot feathers; Rabbit epithelium; Rat epithelium; Rat serum proteins; Rat urine proteins; Sheep epithelium; Turkey feathers |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg; Egg white; Egg yolk; Turkey meat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Anchovy; Blue mussel; Clam; Codfish; Crab; Crayfish; Hake; Herring; Langust (spiny lobster); Lobster; Mackerel; Octopus; Oyster; Pacific squid; Plaice; Red snapper; Salmon; Scallop; Shrimp; Squid; Trout; Tuna |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Apricot; Avocado; Banana; Capsicum; Carrot; Celery; Cherry; Cucumber; Garlic; Grape; Grapefruit; Kiwi; Lemon citrus; Mandarin (tangerine, clementine, satsumas) citrus; Mango; Melon; Olive - Black, fresh; Onion; Orange citrus; Papaya; Peach; Pear; Pineapple; Potato; Pumpkin; Strawberry; Sweet potato; Tomato |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Galactose-α-1,3-galactose thyroglobulin - Bovine; Mutton; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Casein; Cheese - Cheddar type; Cheese - Mould type; Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Cacao; Coffee; Mushroom; Omega-5-gliadin; Yeasts |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Barley; Brazil nut; Buck wheat; Cashew nut; Chick pea; Coconut; Corn; Gluten; Green bean; Hazelnut; Lentil; Linseed; Lupin seed; Macadamia nut; Maize; Oat; Pea; Peanut; Pecan nut; Pinenut; Pistachio; Poppy seed; Red kidney bean; Rice; Rye; Sesame seed; Soy bean; Spelt wheat; Walnut; Wheat; White bean |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [spices] allergens) | Serum | Anise; Basil; Caraway; Cardamon; Chilli pepper; Clove; Fennel seed; Ginger; Mace; Mustard; Vanilla |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Barley; Bermuda grass; Cocksfoot; Cultivated oat; Cultivated rye; Cultivated wheat; Johnson grass; Kentucky blue; Meadow fescue; Meadow grass; Rye grass; Sweet vernal grass; Timothy grass; Wild rye grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | Fire ant; German cockroach; Horse fly Tabanus spp.; Mosquito |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Anisakis; Aspergillus fumigatus; Candida albicans; Cladosporium herbarum; Penicillium chrysogenum (formerly Penicillium notatum) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Chloramine-T; Formaldehyde/formalin; Hexamethylene diisocyanate (1,6-hexamethylene diisocyanate; 1,6-HDI); Latex; Methylene diphenyl diisocyanate (MDI, isocyanate MDI, diphenylmethane diisocyanate); Oxirane (ethyleneoxide); Phthalic anhydride; Sunflower seed; Toluene-2,4-diisocyanate (2,4-TDI) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; Cedar; Eucalyptus; Maple leaf sycamore; Melaleuca; Olive; Silver birch; White pine; Willow salix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Common wasp (yellow jacket) venom; European hornet venom; European paper wasp venom; Honey bee venom; Paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Goosefoot; Lupin; Mugwort; Plantain - English; Rapeseed; Scale; Western ragweed |
| Immunopathology - Single HLA antigen typing | Blood | HLA-B27 |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
Immunopathology
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen | CD117 |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-cyclic citrullinated peptide antibodies (CCP) |
| Anti-thyroid peroxidase antibodies (TPO) | ||
| Anti-thyroglobulin antibodies (Tg) | ||
| Anti-thyrotropin receptor antibodies (TSHR) | ||
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin |
| Serum | Albumin; Detection and amount of paraproteins; α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | |
| Serum; Urine | Characterisation of paraproteins | |
| Urine | Albumin; Detection and amount of paraproteins; α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Cytomegalovirus (CMV); Hepatitis B virus core antibody (anti-HBc) - Total |
Microbiology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2021
Last Activity Date
12 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Agglutination; Colour; Morphology; Motility; Sperm number; Viscosity; Volume; pH |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis for post vasectomy and/or examination of cervical mucus | Semen | Presence of spermatozoa |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Blood | Bacteria; Pathogenic microorganisms |
| Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Sputum; Tissues; Urine | Antibiotic susceptibility; Bacteria; Pathogenic microorganisms | |
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Bacteria; Pathogenic microorganisms | ||
| Blood; Cerebrospinal fluid (CSF); Fluids; General swabs; Sputum; Tissues; Urine | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Urine | Bacteria; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Microbiology - Environmental investigations and/or infection control | Blood transfusion bags; Dialysis waters; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility |
| Environmental swabs | Bacterial organism identification - Acinetobacter; Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Methicillin resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin resistant Enterococcus (VRE) | |
| Microbiology - Environmental investigations and/or infection controlEmail from AR (Rebecca Jackson) to MF 26/08/2020 requesting withdrawal of scope line | Spore strips | Bacterial growth - Sterility |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Blood culture | Methicillin resistant Staphylococcus aureus (MRSA) |
| Nasal swabs | Methicillin resistant Staphylococcus aureus (MRSA) | |
| Throat swabs; Wound swabs | Methicillin resistant Staphylococcus aureus (MRSA) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasal aspirates/washes; Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Nasopharyngeal aspirate; Throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Respiratory specimens | Mycobacteria identification |
| Mycobacteria identification | ||
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection, isolation and identification of yeasts and fungal elements | Blood; Hair; Nails; Skin scrapings | Fungi identification |
| Fungi identification | ||
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cysts; Ova; Parasites |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Cytomegalovirus (CMV); Hepatitis B virus core antibody (anti-HBc) - Total |
Molecular
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2021
Last Activity Date
12 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Cervical specimen; Genital swabs; Gynaecological smears; Liquid based cytology specimens | Human papilloma virus (HPV) |
Molecular Infectious Diseases
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2021
Last Activity Date
12 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Cerebrospinal fluid (CSF) | Neisseria meningitidis |
| Faeces | Aeromonas spp.; Campylobacter spp.; Clostridiodes difficile; Salmonella spp.; Shigella spp.; Yersinia enterocolitica | |
| Genital swabs; Urine | Mycoplasma genitalium | |
| Ureaplasma urealyticum | ||
| Chlamydia trachomatis; Neisseria gonorrhoeae | ||
| Nasal swabs; Nasopharyngeal aspirate; Throat swabs | Bordetella parapertussis; Bordetella pertussis | |
| Sputum; Throat swabs | Chlamydophila pneumoniae; Legionella longbeachae; Legionella pneumophila; Mycoplasma pneumoniae | |
| Tissues | Helicobacter pylori | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Nasal swabs; Sputum; Throat swabs | Pneumocystis pneumoniae |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Blastocystis spp.; Cryptosporidium spp.; Dientamoeba spp.; Entamoeba histolytica; Giardia spp. |
| Genital swabs; Urine | Trichomonas vaginalis | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Bronchial washings; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Cerebrospinal fluid (CSF) | Enterovirus; Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Human parechovirus; Varicella zoster virus (VZV) | |
| Dry swabs | Herpes simplex virus (HSV); Varicella zoster virus (VZV) | |
| Faeces | Adenovirus; Norovirus; Rotavirus | |
| Nasal swabs; Nasopharyngeal aspirate; Throat swabs | Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV) A/B | |
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasal swabs; Throat swabs | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus; Respiratory syncytial virus (RSV); Rhinovirus | |
| Nasopharyngeal aspirate; Nasopharyngeal swabs | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus; Respiratory syncytial virus (RSV); Rhinovirus | |
| Plasma; Serum | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Hepatitis C virus (HCV) viral load - Qualitative | |
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Plasma; Serum | Hepatitis B virus (HBV) viral load; Hepatitis C virus (HCV) viral load |
Serology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2021
Last Activity Date
12 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Faeces | Cryptosporidium antigen; Giardia antigen |
| Plasma; Serum | Adenovirus IgA antibody; Bordetella pertussis total antibody; Strongyloides spp. | |
| Syphilis Treponema pallidum antibody | ||
| Epstein-Barr virus | ||
| Syphilis Treponema pallidum antibody | ||
| Herpes simplex virus (HSV); Measles virus; Mumps virus; Mycoplasma spp.; Parvovirus; Varicella zoster virus (VZV) | ||
| Serum | Dengue virus NS1 antigen | |
| Barmah forest virus total antibody; Coxiella spp.; Dengue virus NS1 antigen; Dengue virus; Ross River virus |
Workplace Drug Testing Facility
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2021
Last Activity Date
12 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | Barbiturates; Buprenorphine; Cannabis; Ethanol; Methadone; Phencyclidine |
ISO 15189 (2012)
Legal
Medicare expiry date
01 Jan 2021
Last Activity Date
12 Apr 2021
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS 4760, section 2 Collection, storage, handling and dispatch | Oral fluid | Handling and dispatch; Sample collection and storage |
| Medico legal drug testing AS 4760, section 5 Confirmatory testing procedures | Oral fluid | 6-Acetylmorphine; Amphetamines; Benzoylecgonine (ecgonine benzoate); Cocaine; Codeine; Ecgonine methyl ester; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
| Medico legal drug testing AS/NZS 4308, appendix A On-site screening procedure | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Opiates |
| Medico legal drug testing AS/NZS 4308, section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Creatinine; Temperature; pH |
| Medico legal drug testing AS/NZS 4308, section 3 General laboratory requirements | Urine | General laboratory requirements as described in AS/NZS 4308 |
| Medico legal drug testing AS/NZS 4308, section 4 Laboratory screening procedures | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Opiates |
| Medico legal drug testing AS/NZS 4308, section 5 Laboratory confirmatory procedures | Urine | 11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; 6-Acetylmorphine; 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Codeine; Diazepam; Ecgonine methyl ester; Ephedrine; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Nordiazepam; Oxazepam; Phentermine; Pseudoephedrine (PSE); Temazepam; α-Hydroxyalprazolam |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
3158
Site No.
3151
Print date
20 Jan 2022
END OF SCOPE